Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Chen, Hanyong ^a   Yao, Ke ^a   Nadas, Janos ^a   Bode, Ann M ^a   Malakhova, Margarita ^a   Oi, Naomi ^a   Li, Haitao ^a   Lubet, Ronald A ^b   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3,3' DI O ETHYLQUERCETIN; 5 HYDROXY 4' METHOXY 7 METHYLFLAVONE; DIMEFLINE; FLAVONOID; ISORHAMNETIN; ISOWOGONIN; KAEMPFEROL; KUMATAKENIN; MITOFLAXONE; PEDALITIN; QUERCETIN; QUERCETIN 3 SULFATE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; TUMOR PROTEIN;

ANALYTIC METHOD; ARTICLE; CANCER PREVENTION; DRUG TARGETING; MOLECULAR DOCKING; PHARMACOPHORE; PHYTOCHEMISTRY; PREDICTION; PROTEIN TARGETING; SHAPE SIMILARITY SCREENING; VIRTUAL SCREENING; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER INTERFACE; DRUG SCREENING; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PROTEIN CONFORMATION; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HUMANS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; PROTEIN CONFORMATION; USER-COMPUTER INTERFACE;

EID: 84861714064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038261     Document Type: Article

References (55)

1. Birt DF, Hendrich S, Wang WQ, (2001) Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics 90: 157-177.
2. Harborne JB, Williams CA, (2000) Advances in flavonoid research since 1992. Phytochemistry 55: 481-504.
3. Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, et al. (2007) Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnology Journal 2: 1214-1234.
4. Pietta PG, (2000) Flavonoids as antioxidants. Journal of Natural Products 63: 1035-1042.
5. Bravo L, (1998) Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutrition Reviews 56: 317-333.
6. Ososki AL, Kennelly EJ, (2003) Phytoestrogens: A review of the present state of research. Phytotherapy Research 17: 845-869.
7. Reynaud J, Guilet D, Terreux R, Lussignol M, Walchshofer N, (2005) Isoflavonoids in non-leguminous families: an update. Natural Product Reports 22: 504-515.
8. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al. (1987) Genistein, a specific inhibitor of tyrosine-specific protein-kinases. Journal of Biological Chemistry 262: 5592-5595.
9. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
10. Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, et al. (2010) Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene Ahydrolase. Cancer Res 70: 9755-9764.
11. Chen X, Wang S, Wu N, Yang CS, (2004) Leukotriene A4 hydrolase as a target for cancer prevention and therapy. Current Cancer Drug Targets 4: 267-283.
12. Kinoshita T, Lepp Z, Kawai Y, Terao J, Chuman H, (2006) An integrated database of flavonoids. Biofactors 26: 179-188.
13. Rolo-Naranjo A, Codorniu-Hernandez E, Ferro N, (2010) Quantum Chemical Associations Ligand-Residue: Their Role to Predict Flavonoid Binding Sites in Proteins. Journal of Chemical Information and Modeling 50: 924-933.
14. Suetsugi M, Su L, Karlsberg K, Yuan YC, Chen S, (2003) Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Molecular Cancer Research 1: 981-991.
15. Lee KW, Bode AM, Dong Z, (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11: 211-218.
16. Rester U, (2008) From virtuality to reality- Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective. Current Opinion in Drug Discovery & Development 11: 559-568.
17. Lyne PD, (2002) Structure-based virtual screening: an overview. Drug Discovery Today 7: 1047-1055.
18. Irwin JJ, Shoichet BK, (2005) ZINC- A free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling 45: 177-182.
19. Hartshorn MJ, Verdonk ML, Chessari G, Brewerton SC, Mooij WTM, et al. (2007) Diverse, high-quality test set for the validation of protein-ligand docking performance. Journal of Medicinal Chemistry 50: 726-741.
20. Cho YY, Bode AM, Mizuno H, Choi BY, Choi HS, et al. (2004) A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase alpha in neoplastic cell transformation and tumor development. Cancer Res 64: 3855-3864.
21. Clark DE, Errington TM, Smith JA, Frierson HF Jr, Weber MJ, et al. (2005) The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res 65: 3108-3116.
22. David JP, Mehic D, Bakiri L, Schilling AF, Mandic V, et al. (2005) Essential role of RSK2 in c-Fos-dependent osteosarcoma development. J Clin Invest 115: 664-672.
23. Cho YY, Yao K, Pugliese A, Malakhova ML, Bode AM, et al. (2009) A regulatory mechanism for RSK2 NH(2)-terminal kinase activity. Cancer Res 69: 4398-4406.
24. Liu K, Cho YY, Yao K, Nadas J, Kim DJ, et al. (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem 286: 2057-2066.
25. Lee KM, Lee KW, Jung SK, Lee EJ, Heo YS, et al. (2010) Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem Pharmacol 80: 2042-2049.
26. Cho YY, Yao K, Kim HG, Kang BS, Zheng D, et al. (2007) Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res 67: 8104-8112.
27. Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM, et al. (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res 65: 1027-1034.
28. Hollman PC, Katan MB, (1999) Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 37: 937-942.
29. Malakhova M, Kurinov I, Liu K, Zheng D, D'Angelo I, et al. (2009) Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2. PLoS ONE 4: e8044.
30. Malakhova M, Tereshko V, Lee SY, Yao K, Cho YY, et al. (2008) Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2. Nat Struct Mol Biol 15: 112-113.
31. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Research 28: 235-242.
32. (2011) Phase v3.3 Schrödinger Suite: User Manual. Schrödinger, LLC.
33. (2011) Schrödinger Suite Schrödinger, LLC.
34. Willett P, Barnard JM, Downs GM, (1998) Chemical similarity searching. Journal of Chemical Information and Computer Sciences 38: 983-996.
35. Downs GM, Willett P, Fisanick W, (1994) Similarity Searching and Clustering of Chemical-Structure Databases Using Molecular Property Data. Journal of Chemical Information and Computer Sciences 34: 1094-1102.
36. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, et al. (2008) Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 68: 6021-6029.
37. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, et al. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919.
38. (2011) Glide,V5.6, Schrödinger Suite: User manual. Schrödinger, LLC.
39. Cavasotto CN, Abagyan RA, (2004) Protein flexibility in ligand docking and virtual screening to protein kinases. Journal of Molecular Biology 337: 209-225.
40. Kim JE, Lee DE, Lee KW, Son JE, Seo SK, et al. (2011) Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer Prev Res (Phila) 4: 582-591.
41. Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, et al. (2007) Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther 6: 163-172.
42. Jung SK, Lee KW, Byun S, Lee EJ, Kim JE, et al. (2010) Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo. Carcinogenesis 31: 911-917.
43. Jung SK, Lee KW, Kim HY, Oh MH, Byun S, et al. (2010) Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem Pharmacol 79: 1455-1461.
44. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
45. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao JT, et al. (2008) Dietary flavonoid intake and lung cancer-a population-based case-control study. Cancer 112: 2241-2248.
46. Fitch BG, Rayshubskiy A, Eleftheriou M, Ward TJC, Giampapa M, et al. (2006) Blue matter: Strong scaling of molecular dynamics on blue Gene/L. Computational Science- Iccs 2006, Pt 2, Proceedings 3992: 846-854.
47. Germain RS, Fitch BG, Rayshubskiy A, Eleftheriou M, Pitman MC, et al. (2005) Blue Matter on Blue Gene/L: Massively Parallel Computation for Biomolecular Simulation. presented at 3rd IEEE/ACM/IFIP international conference on Hardware/software codesign and system synthesis (CODES+ISSS ' 05): 207-212.
48. Lee DE, Lee KW, Jung SK, Lee EJ, Hwang JA, et al. (2011) 6,7,4′-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2. Carcinogenesis 32: 629-635.
49. Lee DE, Lee KW, Song NR, Seo SK, Heo YS, et al. (2010) 7,3′,4′-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase. J Biol Chem 285: 21458-21466.
50. Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, et al. (2008) Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68: 946-955.
51. Urusova D, Shim J, Kim DJ, Jung SK, Zykova T, et al. (2011) Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res (Phila) in press.
52. Jeong CH, Bode AM, Pugliese A, Cho YY, Kim HG, et al. (2009) [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res 69: 5584-5591.
53. Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ, et al. (2011) Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 32: 921-928.
54. Kang NJ, Lee KW, Shin BJ, Jung SK, Hwang MK, et al. (2009) Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 30: 321-330.
55. Kwon JY, Lee KW, Kim JE, Jung SK, Kang NJ, et al. (2009) Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcinogenesis 30: 1932-1940.